Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-TALC phase II talc pleurodesis for malignant pleural effusion
jRCT2091220029Phase 2Completed
- Sponsor
- National Hospital Organization Nagoya Medical Center
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of talc in malignant pleural effusion (MPE), sponsored by National Hospital Organization Nagoya Medical Center. Primary endpoint: Pleural effusion control rate on day 30. Started Jun 2009; status: completed.
02
Drugs
talc
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on jRCT2091220029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220029.